AstraZeneca in Blockbuster Anti-depressant Deal

By Taskin Ahmed

Pharma Deals Review: Vol 2009 Issue 12 (Table of Contents)

Published: 11 Dec-2009

DOI: 10.3833/pdr.v2009.i12.1284     ISSN: 1756-7874

Section: Licensing



AstraZeneca has inked a global license collaboration with Targacept for the latter’s experimental antidepressant, TC-5214, in a deal valued at US$1...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details